Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Influenza

  Free Subscription


09.04.2018

1 Arch Virol
1 Cell
2 Epidemiol Infect
1 Pediatrics
3 PLoS One
1 Proc Natl Acad Sci U S A
2 Vaccine
2 Virus Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arch Virol

  1. NAGY A, Dan A, Cernikova L, Vitaskova E, et al
    Microevolution and independent incursions as main forces shaping H5 Hemagglutinin diversity during a H5N8/H5N5 highly pathogenic avian influenza outbreak in Czech Republic in 2017.
    Arch Virol. 2018 Apr 5. pii: 10.1007/s00705-018-3833.
    PubMed     Text format     Abstract available


    Cell

  2. CHEN YQ, Wohlbold TJ, Zheng NY, Huang M, et al
    Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies.
    Cell. 2018;173:417-429.
    PubMed     Text format     Abstract available


    Epidemiol Infect

  3. DOMINGUEZ A, Romero-Tamarit A, Soldevila N, Godoy P, et al
    Effectiveness of antiviral treatment in preventing death in severe hospitalised influenza cases over six seasons.
    Epidemiol Infect. 2018 Apr 2:1-10. doi: 10.1017/S0950268818000663.
    PubMed     Text format     Abstract available

  4. ZHANG J, Nawata K
    Multi-step prediction for influenza outbreak by an adjusted long short-term memory.
    Epidemiol Infect. 2018 Apr 2:1-8. doi: 10.1017/S0950268818000705.
    PubMed     Text format     Abstract available


    Pediatrics

  5. DUNKLE LM, Izikson R, Patriarca PA, Goldenthal KL, et al
    Safety and Immunogenicity of a Recombinant Influenza Vaccine: A Randomized Trial.
    Pediatrics. 2018 Apr 2. pii: peds.2017-3021. doi: 10.1542/peds.2017-3021.
    PubMed     Text format     Abstract available


    PLoS One

  6. REEVES AB, Hall JS, Poulson RL, Donnelly T, et al
    Influenza A virus recovery, diversity, and intercontinental exchange: A multi-year assessment of wild bird sampling at Izembek National Wildlife Refuge, Alaska.
    PLoS One. 2018;13:e0195327.
    PubMed     Text format     Abstract available

  7. JANG H, Elaish M, Kc M, Abundo MC, et al
    Efficacy and synergy of live-attenuated and inactivated influenza vaccines in young chickens.
    PLoS One. 2018;13:e0195285.
    PubMed     Text format     Abstract available

  8. RAJENDRAN M, Sun W, Comella P, Nachbagauer R, et al
    An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations.
    PLoS One. 2018;13:e0194830.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  9. KADAM RU, Wilson IA
    A small-molecule fragment that emulates binding of receptor and broadly neutralizing antibodies to influenza A hemagglutinin.
    Proc Natl Acad Sci U S A. 2018 Apr 2. pii: 1801999115.
    PubMed     Text format     Abstract available


    Vaccine


  10. Response to three Letters to the Editor regarding: Donahue JG, et al. "Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12". Vaccine 35 (2017) 5314-5322.
    Vaccine. 2018;36:2231-2232.
    PubMed     Text format    

  11. WENDLANDT R, Cowling BJ, Chen Y, Havers F, et al
    Knowledge, attitudes and practices related to the influenza virus and vaccine among older adults in Eastern China.
    Vaccine. 2018 Mar 29. pii: S0264-410X(18)30408.
    PubMed     Text format     Abstract available


    Virus Res

  12. SUPTAWIWAT O, Kongchanagul A, Boonarkart C, Auewarakul P, et al
    H1N1 seasonal influenza virus evolutionary rate changed over time.
    Virus Res. 2018 Mar 30. pii: S0168-1702(17)30881.
    PubMed     Text format     Abstract available

  13. ZHANG D, Lin G, Zhang K, Yi L, et al
    Implications of and lessons learned from external assurance of eight influenza diagnostics in China.
    Virus Res. 2018;249:110-115.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: